Wu Wei, Director of the Jiangxi Provincial Drug Administration, and his delegation paid a visit to Hongda Group to supervise workplace safety.


Release date:

2024-02-06

On February 2, Wu Wei, Party Secretary and Director of the Jiangxi Provincial Drug Administration, led a delegation to Jiangxi Hongda Medical Device Group Co., Ltd. to conduct an inspection of workplace safety.

Director Wu Wei and his delegation conducted an on-site inspection of Hongda Group’s workplace safety practices and fire‑safety equipment, and thoroughly inquired about the company’s specific measures for fulfilling safety responsibilities and enhancing its safety management system. Wang Haiyin, General Manager of Hongda Group, briefed the supervisory team on the company’s workplace safety management efforts.

Director Wu Wei also conveyed to those present the recent important instructions of General Secretary Xi Jinping on work safety, as well as the spirit of the Provincial Party Committee Standing Committee meeting and the province-wide emergency meeting on work safety. He emphasized that enterprises must earnestly fulfill their primary responsibility for safety, strictly comply with relevant laws and regulations, and ensure that work safety is foolproof.

Participants in this supervisory inspection included Wu Wei, Party Secretary and Director of the Provincial Drug Administration; Liu Bin, Member of the Party Leadership Group and Deputy Director of the Provincial Drug Administration; Xu Qiang, Secretary of the Jinxiang County Party Committee; Qian Gaotai, Member of the Standing Committee of the Jinxiang County Party Committee and Secretary of the Political and Legal Affairs Commission; Xiong Yihui, Deputy County Mayor of the Jinxiang County People’s Government; Wan Yong, Director of the Provincial Drug Inspection Center; Guo Bo, Deputy Director of the Comprehensive and Planning & Finance Division of the Provincial Drug Administration; Zhao Songyun, Fourth-Level Researcher in the Medical Device Supervision and Management Division of the Provincial Drug Administration; and Xu Jinghong, Director of the Eighth Inspection Team of the Provincial Drug Inspection Center, among others.

Hongda Group attaches great importance to this supervisory inspection. Chairman Wang Jianghua, General Manager Wang Haiyin, and the company’s management team accompanied the team throughout the process, actively cooperated with the inspection, and carefully listened to the supervisory group’s comments and recommendations. Following this safety oversight, Hongda Group will further strengthen its production‑safety management, upgrade its fire‑protection systems, and earnestly fulfill its primary responsibility for workplace safety. The company will adopt an even more rigorous approach to continuously enhance its safety‑management standards, thereby creating a safer, more reliable working environment for its employees and the wider community.